Professional Documents
Culture Documents
Case Discussion Tka
Case Discussion Tka
Jaleco
Level 2 Resident
I. General Data
Patient’s Name: G.P.
Age: 46 y.o.
Sex: F
Civil Status: Married
Birthday: 07/07/1977
Nationality: Filipino
Religion: Roman Catholic
Address: B25, L52, Country Homes Subdivision, Balabago, Jaro, Iloilo City, Iloilo
However, a month PTA, patient’s knee pain persisted and is no longer relieved by medications,
and with note of associated stiffness of the affected knee joint. The patient sought consult to
the Department of Orthopedics and was apprised & scheduled for elective surgery, thus
admission.
Anicteric sclerae, symmetrical chest expansion, clear breath sounds, adynamic precordium
normal cardiac rate with regular rhythm, no note of murmurs, soft abdomen, (+) limited ROM
on right knee, (+) pain on right knee, full peripheral pulses. No sensorimotor deficits noted.
The patient was placed on NPO status 8 hours prior the procedure, and was premedicated
with 1) Omeprazole 40 mg IV 1 hour PTOR, and 2) Metoclopramide 10 mg slow IV 1 hour PTOR.
The patient was go on OR with available blood (1 unit of whole blood).
X. Proposed Procedure
Total Knee Arthroplasty Right
Upon cutting, the patient was stable with vital signs of BP 100/60, HR 90, RR 20, SpO2 100%.
Around twenty minutes from cutting time, a dose of Midazolam 1mg IV, and Nalbuphine 2mg
slow IV was given for sedation. At 1 hour and 15 minutes from cutting time, there was note of
blood loss of around 300cc, which was around 30% of the computed allowable blood loss of
860cc, and blood transfusion of 1 unit of whole blood was initiated.
At around 15 minutes before the end of the procedure, Ketorolac 30mg IV was given with note
of a negative skin test. Overall the intraoperative course was unremarkable with the operation
lasting for approximately 3 hours. There was no note of intraoperative hypotension nor
tachycardia. A total of 1.2 L of crystalloids was transfused, with ongoing blood transfusion,
urine output was noted to be 0.9cc/kg/hr. The patient’s vital signs were BP 120/80, HR 85, RR
20, SpO2 100% prior transfer to the Post Anesthesia Care Unit for post-operative monitoring.
Post-operative medications given are as follows: 1) Ketorolac 30 mg IV ANST every 8 hours for
2 more doses, and is then shifted to, 2) Celecoxib 200 mg/cap, 1 cap PO every 12 hours for 7
days, 3) Paracetamol 1g IV every 8 hours for 3 doses, 4) Tramadol 50 mg slow IV every 6 hours
as needed for breakthrough pain, 5) Ondansetron 4 mg slow IV every 8 hours as needed for
nausea or vomiting. CBC and APC were then repeated 6 hours post blood transfusion.
At the wards at 24 hours post-op, the patient was still GCS 15 with stable vital signs, still NRS
0/10, and with unremarkable PE findings.
XIV. Discussion
Total knee arthroplasty (TKA) is a very common operation that is increases in frequency as the
population ages. Because TKA involves the cutting and cementing of two long bones, the
femur and tibia, these procedures have a painful recovery with a high incidence of chronic
pain following both primary and revision procedures. It is important to create an appropriate
postoperative analgesia plan to minimize pain while maximizing early mobilization.
TKA causes moderate to severe postoperative pain for most patients. The goals for pain
control after TKA are to provide excellent analgesia, early mobilization and rehabilitation, and
to minimize the use of opioids. A multimodal approach to pain management allows
administration of lower doses of various medications and less dense regional anesthesia
techniques than would be required otherwise, and therefore reduced side effects and
complications.
Multimodal, opioid-sparing strategies for postoperative pain control may include regional
analgesia techniques (eg, peripheral nerve blocks, LA infiltration, continuous epidural
analgesia, neuraxial opioids), in addition to multimodal systemic analgesics.
Spinal anesthesia provides consistent, dense, bilateral anesthesia. A single injection spinal can
reliably provide a duration of block adequate for primary unilateral TKA. The duration of spinal
anesthesia is determined by the local anesthetic (LA) used and the dose.
Epidural anesthesia may be used for prolonged procedures (eg, bilateral or revision TKA) in
which the duration of surgery is expected to outlast spinal anesthesia or when postoperative
epidural analgesia is desired.
Analgesia
The optimal analgesia for TKA is a complex and evolving topic. Regional anesthesia improves
patient pain outcomes compared to traditional opioid regimens. Ultrasound-guided regional
anesthesia has led to a significant increase in the use of nerve blocks and catheters as
components of postoperative analgesic regimens. A balanced multimodal analgesic approach
has the potential to maximize analgesic efficacy while minimizing side effects.
The femoral, sciatic, and obturator nerves provide sensation to the knee joint. The most
commonly utilized peripheral nerve blocks are the LBP, fascia iliaca (3-in-1 block), FNB, and
adductor canal (or saphenous) nerve blocks. These blocks can be performed in combination
with a sciatic nerve block and/or an obturator nerve block. Literature and clinical practice
continue to evolve regarding which blocks or combination of blocks best facilitate
rehabilitation and postoperative mobilization, thereby reducing time to hospital discharge,
enhancing cost effectiveness, and reducing the risk for complications such as ambulation-
related falls.
Healthy, opioid naïve patients who undergo unicompartmental, primary, or simple revision
TKA are often candidates for rapid recovery with the potential for "fast-track" status with a
reduced length of stay. Pain control strategies should include a muscle sparing regional
anesthetic technique (adductor canal, interspace between popliteal artery and posterior
capsule of the knee [IPACK], periarticular injection [PAI]) to facilitate early physical therapy.
The majority of the innervation to the knee joint arises from the femoral nerve (nerves to the
vastus medialis, intermedius, and lateralis, medial and intermediate femoral cutaneous, and
saphenous nerves), a smaller but still significant contribution from the sciatic nerve (peroneal
and tibial nerves), and yet even smaller contribution from the lateral femoral cutaneous and
posterior obturator nerves. The saphenous nerve is the sensory component of the femoral
nerve.
Adductor canal block
The ACB involves block of the saphenous nerve (sensory only), likely the nerve to the vastus
medialis, and possibly the posterior branch of the obturator nerve. It is classically performed
at the level of the mid-thigh, midway between the anterior superior iliac spine and the base
of the patella. However, the extent and location of the adductor canal is debated by
anatomists, and this point on the thigh may actually overlay the inferior aspect of the femoral
triangle. ACB results in less quadriceps weakness than femoral nerve block because the ACB
generally spares the nerves to the rectus femoris and vastus intermedius muscles.
Neither the femoral nerve block nor the ACB provide complete analgesia of the knee, because
they do not include the contributions from the sciatic nerve. For patients who undergo
complex revision, who are poor candidates for fast-track protocol, or who require complete
analgesia of the knee because of opioid tolerance or chronic pain, a femoral plus sciatic nerve
block may be performed.
Interspace between popliteal artery and posterior capsule of the knee (IPACK) block – The
IPACK block is designed to block the small sensory branches of the sciatic nerve that travel in
this space without affecting motor components. The IPACK block provides analgesia for the
posterior portion of the knee only, and would likely be ineffective alone for postoperative
analgesia; thus it is often performed along with an ACB in a multimodal analgesic pathway.
The IPACK block may be an alternative to PAI or provide additional coverage for posterior knee
pain.
XV. References
1. Barash, P., et al. (2017) Clinical Anesthesia, 8th edition
2. Amundson, A., et al. “Anesthesia for total knee arthroplasty”. UptoDate. Feb 09, 2023